Main menu

Pages

BrainScope was named "Best New Diagnostic Technology Solution" in the 2022 MedTech Breakthrough Awards Program

BETHESDA, Maryland – (work wire) – The creator of the BrainScope Brain Assessment Device announced today that it has been selected as the “Best New Diagnostic Technology Solution” in the sixth annual MedTech Breakthrough Awards Program of MedTech Breakthrough, an independent market intelligence organization that recognizes the best companies, technologies and products in the global health and medical technology markets.

BrainScope is a Class 2 FDA-approved medical device that uses artificial intelligence (AI) and machine learning (ML) technology to identify objective biomarkers of structural and functional brain injury in patients with suspected mild traumatic brain injury (mTBI).

BrainScope allows clinicians to sort mTBI at the point of care without radiation with an apparent 30%-60% reduction in unnecessary head computed tomography (CT) scans. The BrainScope is suitable for patients presenting to emergency departments, urgent care centers, and concussion clinics as well as patients who play sports or are in the military. In less than 20 minutes from patient preparation to result, BrainScope provides an easy-to-use, intuitive tool for the operator and accurate, instantly actionable results for the medical professional.

“What an honor to receive this award from MedTech Breakthrough. This validates the work of our entire team as we strive to improve brain health by providing objective diagnostic insights that enable better patient care,” said Dr. Deku Mandivia, Chief Medical Officer of BrainScope. “BrainScope helps answer key questions for clinicians and patients — whether a patient Has he experienced a brain haemorrhage or concussion, and whether he is ready to resume normal activities. The technological change that BrainScope brings has immediate benefits for both the patient and the emergency department – the timing of this 21st century approach couldn’t be better. ”

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize innovation, hard work, and success in a range of health and medical technology categories, including telehealth, clinical management, patient engagement, electronic health records (EHR), virtual and medical care. devices, medical data and many more. This year’s program attracted over 3,900 nominations from over 15 different countries from all over the world.

“Traumatic brain injury is approaching epidemic levels in the United States, where five million patients with head injuries receive care in emergency departments each year, and while CT scans remain the standard of care, these tests can only detect the presence or absence of bleeding in the Brain James Johnson, MD, MedTech Breakthrough, said: “BrainScope is the only system that helps evaluate the full spectrum of mild traumatic brain injuries including brain haemorrhage and concussion. It’s truly point-of-care and takes only minutes from patient preparation to results – a real achievement we’re thrilled to recognize in our sixth annual MedTech Breakthrough Awards Program. ”

Exceptionally validated, published, and patented, BrainScope’s technology has been validated by 29 clinical studies, over 14,000 subject evaluations, 8 FDA and 2 Health Canada certifications, MDSAP and ISO13485, and 31 peer-reviewed publications. Before peers and 90 global patents.

BrainScope’s EEG-authorized algorithms help clinicians rule out bleeding in the brain, assess concussion and severity of concussion, and aid in accurate diagnosis and referral along the continuum of care.

About BrainScope

BrainScope is a neuromedical technology company that improves brain health by providing objective diagnostic insights that enable better patient care. BrainScope leads the way in rapid and objective assessment of brain-related conditions, starting with mild traumatic brain injury (mTBI), using multiple integrated assessment capabilities, artificial intelligence (AI) and digitization. The company’s technology supports the American College of Emergency Physicians (ACEP) selection of Wisely® campaign to avoid head CT scans in emergency department patients with minor head injuries. BrainScope’s innovative EEG-based algorithms derived from artificial intelligence enable clinicians to quickly perform accurate head injury assessments, treating the full spectrum of traumatic brain injuries from structural (brain hemorrhage) to functional (concussion), providing for the first time a complete picture of the injury, And do it in less time and without radiation. For more information, please visit www.brainscope.com.

About MedTech Breakthrough

The MedTech Breakthrough Awards are part of Tech Breakthrough, a leading platform for market intelligence and recognition of global technology innovation and leadership, dedicated to honoring excellence in medical and health technology companies, products, services, and people. The MedTech Breakthrough Awards provide a platform for public recognition of the achievements of companies and cutting-edge medical and health products in categories including patient engagement, mobile health, health and fitness, clinical management, healthcare IoT, medical data, healthcare cybersecurity and more. For more information, please visit MedTechBreakthrough.com.

reactions

Comments